Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

NCT04665960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2021-05-11

No results posted yet for this study

Summary

The investigators aim to develop expert consensus statements on infection control management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in intensive care units (ICU).

Conditions

  • Covid19
  • SARS-CoV Infection
  • SARS Pneumonia
  • Coronavirus Infection
  • Infection

Sponsors & Collaborators

  • NMC Specialty Hospital

    lead OTHER

Principal Investigators

  • Sheila Myatra, MD · Tata Memorial Hospital, Mumbai, India

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-29
Primary Completion
2021-04-25
Completion
2021-05-01

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04665960 on ClinicalTrials.gov